Castellanos Ingrid J, Al-Azzam Wasfi, Griebenow Kai
Department of Chemistry, University of Puerto Rico, Río Piedras Campus, P.O. Box 23346, San Juan, Puerto Rico 00931-3346.
J Pharm Sci. 2005 Feb;94(2):327-40. doi: 10.1002/jps.20243.
The effectiveness of the covalent modification of alpha-chymotrypsin with methoxy poly(ethylene glycol) (PEG) to afford its stabilization during encapsulation in poly(lactic-co-glycolic) acid (PLGA) microspheres by a solid-in-oil-in-water method was investigated. alpha-Chymotrypsin was chemically modified with PEG (M(w) = 5000) using molar ratios of PEG-to-chymotrypsin ranging from 0.4 to 96. Various conjugates were obtained and the amount of PEG modification was determined by capillary electrophoresis. In this investigation, only those conjugates with PEG/chymotrypsin molar ratios between approximately 1 and 8 were considered because higher levels of modification caused protein instability even before encapsulation. The stability and functionality of the chymotrypsin formulations were investigated before encapsulation by measuring enzyme kinetics, thermal stability, and tertiary structure intactness, and after the initial lyophilization process by determining the secondary structure content. These stability parameters were related to select ones after encapsulation in PLGA microspheres (specifically, the amount of insoluble aggregates, residual enzyme activity, and magnitude of protein structural perturbations). The results show that the more stable the protein conformation before encapsulation was, the higher was the retention of the specific activity after encapsulation. In contrast, no relationship was found between the protein stability before encapsulation and the magnitude of encapsulation-induced protein aggregation. Even the lowest level of modification (PEG-to-chymotrypsin molar ratio of 0.7) drastically reduced the amount of insoluble aggregates from 18% for the nonmodified protein to 4%. The results demonstrate that PEG modification was able to largely prevent chymotrypsin aggregation and activity loss upon solid-in-oil-in-water encapsulation in PLGA microspheres. It is demonstrated that it is essential to optimize the degree of protein modification to ascertain protein stability upon encapsulation.
研究了用甲氧基聚(乙二醇)(PEG)对α-糜蛋白酶进行共价修饰,以便在通过水包油包固法将其包封于聚(乳酸-共-乙醇酸)(PLGA)微球过程中实现稳定化的效果。使用PEG与α-糜蛋白酶的摩尔比范围为0.4至96,用PEG(M(w)=5000)对α-糜蛋白酶进行化学修饰。获得了各种缀合物,并通过毛细管电泳确定PEG修饰量。在本研究中,仅考虑那些PEG/糜蛋白酶摩尔比在约1至8之间的缀合物,因为更高水平的修饰甚至在包封之前就导致蛋白质不稳定。在包封之前,通过测量酶动力学、热稳定性和三级结构完整性来研究糜蛋白酶制剂的稳定性和功能,在初始冻干过程之后,通过确定二级结构含量来进行研究。这些稳定性参数与包封于PLGA微球之后的选定参数相关(具体而言,不溶性聚集体的量、残留酶活性和蛋白质结构扰动的程度)。结果表明,包封前蛋白质构象越稳定,包封后比活性的保留率越高。相反,未发现包封前蛋白质稳定性与包封诱导的蛋白质聚集程度之间存在关系。即使是最低水平的修饰(PEG与糜蛋白酶的摩尔比为0.7)也能将不溶性聚集体的量从未修饰蛋白质的18%大幅降低至4%。结果表明,PEG修饰能够在很大程度上防止α-糜蛋白酶在水包油包固法包封于PLGA微球过程中的聚集和活性损失。结果表明,优化蛋白质修饰程度对于确定包封时蛋白质的稳定性至关重要。